 Connection
Kaustav Bera to Chemotherapy, Adjuvant
This is a "connection" page, showing publications Kaustav Bera has written about Chemotherapy, Adjuvant.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.117 |
|
|
|
-
Wang X, Bera K, Barrera C, Zhou Y, Lu C, Vaidya P, Fu P, Yang M, Schmid RA, Berezowska S, Choi H, Velcheti V, Madabhushi A. A prognostic and predictive computational pathology image signature for added benefit of adjuvant chemotherapy in early stage non-small-cell lung cancer. EBioMedicine. 2021 Jul; 69:103481.
Score: 0.041
-
Vaidya P, Bera K, Gupta A, Wang X, Corredor G, Fu P, Beig N, Prasanna P, Patil P, Velu P, Rajiah P, Gilkeson R, Feldman M, Choi H, Velcheti V, Madabhushi A. CT derived radiomic score for predicting the added benefit of adjuvant chemotherapy following surgery in Stage I, II resectable Non-Small Cell Lung Cancer: a retrospective multi-cohort study for outcome prediction. Lancet Digit Health. 2020 03; 2(3):e116-e128.
Score: 0.038
-
Vaidya P, Bera K, Gupta A, Wang X, Corredor G, Fu P, Beig N, Prasanna P, Patil PD, Velu PD, Rajiah P, Gilkeson R, Feldman MD, Choi H, Velcheti V, Madabhushi A. CT derived radiomic score for predicting the added benefit of adjuvant chemotherapy following surgery in stage I, II resectable non-small cell lung cancer: a retrospective multicohort study for outcome prediction. Lancet Digit Health. 2020 03; 2(3):e116-e128.
Score: 0.038
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|